2023
Access to urologic cancer care for Medicaid-insured patients
Laditi F, Nie J, Hsiang W, Umer W, Haleem A, Marks V, Buck M, Leapman M. Access to urologic cancer care for Medicaid-insured patients. Urologic Oncology Seminars And Original Investigations 2023, 41: 206.e21-206.e27. PMID: 36740488, DOI: 10.1016/j.urolonc.2023.01.014.Peer-Reviewed Original ResearchConceptsUrologic cancer careCancer careMedicaid insuranceMedicaid acceptanceAcceptance of MedicaidPrimary study outcomeNew Medicaid patientsMedicaid expansion statusNon-expansion statesState Medicaid programsMedicare reimbursement ratesAffordable Care ActVulnerable patientsMedicaid patientsHospital statusKidney tumorsNew diagnosisPatientsHealthcare accessExpansion statusFacility characteristicsNon-teaching facilitiesStudy outcomesAmerican Hospital DirectoryMedicaid
2018
National determinants of active surveillance among patients with clinical stage 1A kidney tumors.
Lu A, Nguyen K, Nolte A, Alimi O, Hsiang W, Ghabili K, Syed J, Shuch B, Leapman M. National determinants of active surveillance among patients with clinical stage 1A kidney tumors. Journal Of Clinical Oncology 2018, 36: 694-694. DOI: 10.1200/jco.2018.36.6_suppl.694.Peer-Reviewed Original ResearchSmall renal massesNational Cancer DatabaseActive surveillanceInitial managementRenal massesCancer DatabaseClinical T1a renal massesMultivariate logistic regression modelFacility-level differencesWest North Central census divisionCancer registry dataT1a renal massesLogistic regression modelsSocio-demographic determinantsDefinitive therapyDefinitive treatmentPatient ageTotal cohortPractice patternsNational utilizationRegistry dataInclusion criteriaCaucasian raceKidney tumorsPatients